Gene · 5350
Papers4,369
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,369
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice. | Front Immunol | 2022 | 35296091 | PubTator, text mining | PubMed |
| Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy. | Dis Model Mech | 2022 | 35293586 | PubTator, text mining | PubMed |
| Obesity and exercise training alter inflammatory pathway skeletal muscle small extracellular vesicle microRNAs. | Exp Physiol | 2022 | 35293040 | PubTator, text mining | PubMed |
| Chronic isoprenaline/phenylephrine vs. exclusive isoprenaline stimulation in mice: critical contribution of alpha1-adrenoceptors to early cardiac stress responses. | Basic Res Cardiol | 2022 | 35286475 | PubTator, text mining | PubMed |
| Genetic variants in Chinese patients with sporadic dilated cardiomyopathy: a cross-sectional study. | Ann Transl Med | 2022 | 35284542 | PubTator, text mining | PubMed |
| Analysis of the long non-coding RNA and mRNA expression profiles associated with lidocaine-induced neurotoxicity in the spinal cord of a rat model. | Neurotoxicology | 2022 | 35283115 | PubTator, text mining | PubMed |
| Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation. | Front Pharmacol | 2022 | 35281886 | PubTator, text mining | PubMed |
| Update of Takotsubo cardiomyopathy: Present experience and outlook for the future. | Int J Cardiol Heart Vasc | 2022 | 35281752 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identifies a Novel Variant (c.1538T > C) of TNNI3K in Arrhythmogenic Right Ventricular Cardiomyopathy. | Front Cardiovasc Med | 2022 | 35274013 | PubTator, text mining | PubMed |
A Comparative Genomic and Safety Assessment of Six Lactiplantibacillus plantarum subsp. argentoratensis Strains Isolated from Spontaneously Fermented Greek Wheat Sourdoughs for Potential Biotechnological Application. | Int J Mol Sci | 2022 | 35269627 | PubTator, text mining | PubMed |
| Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation. | Int J Mol Sci | 2022 | 35269571 | PubTator, text mining | PubMed |
| Redox Implications of Extreme Task Performance: The Case in Driver Athletes. | Cells | 2022 | 35269521 | PubTator, text mining | PubMed |
| The Cardiomyocyte in Heart Failure with Preserved Ejection Fraction-Victim of Its Environment? | Cells | 2022 | 35269489 | PubTator, text mining | PubMed |
| Arrhythmogenic Right Ventricular Cardiomyopathy and Differential Diagnosis with Diseases Mimicking Its Phenotypes. | J Clin Med | 2022 | 35268321 | PubTator, text mining | PubMed |
| Protein-Based Hydrogels: Promising Materials for Tissue Engineering. | Polymers (Basel) | 2022 | 35267809 | PubTator, text mining | PubMed |
| Electrical management of heart failure: from pathophysiology to treatment. | Eur Heart J | 2022 | 35265992 | PubTator, text mining | PubMed |
| The Importance of Time-Course Studies Using Experimental Models of Cardiac Diseases. | Arq Bras Cardiol | 2022 | 35262583 | PubTator, text mining | PubMed |
| Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients. | Basic Res Cardiol | 2022 | 35260914 | PubTator, text mining | PubMed |
| Efficient In Vivo Homology-Directed Repair Within Cardiomyocytes. | Circulation | 2022 | 35254919 | PubTator, text mining | PubMed |
| Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family members. | Stem Cell Res | 2022 | 35247838 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5350/papers?page=47